Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Not yet recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1

Conditions

Endometrial Neoplasms 9Polycystic Ovary Syndrome 4Infertility 3Endometrial Hyperplasia 3Anovulation 2Vitamin D Deficiency 1Turcot syndrome 1Overweight 1Obesity 1Neoplasms 1Carcinoma, Renal Cell 1Carcinoma, Endometrioid 1Breast Neoplasms 1

Interventions

temsirolimus 1sintilimab 1pembrolizumab 1palbociclib 1olaparib 1durvalumab 1defactinib 1copanlisib 1ceralasertib 1Therapeutics 1Restraint, Physical 1Radiation, Ionizing 1RO5126766 1Megestrol Acetate 1Medroxyprogesterone Acetate 1Hysterectomy 1Fulvestrant 1Carboplatin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Carcinoma, Endometrioid × Medroxyprogesterone Acetate × Clear all
NCT06549855 2024-08-12

PD-1 Inhibitor Combined With Progesterone Treatment in FST for Patients With MMRd Endometrial Cancer

Peking University People's Hospital

Phase NA Not yet recruiting
10 enrolled
Gynecologic

Turcot syndrome, Endometrial Neoplasms, Carcinoma, Endometrioid

Data powered by HemOnc (CC BY 4.0) Colophon âš¡